scientific programme
33
tuesday, 24 June 2014
S-13-002
Early life stress and genome wide adaptation
Moshe Szyf, Canada
R. Masart, S. Suomi, N. Provencal, C. Yi
S-13-003
Activation of the Glucocorticoid Receptor: A
possible mediator of genome-wide changes
in DNA-methylation following early trauma
Elisabeth Binder, Germany
S-13-004
Prenatal exposure to a natural disaster and
life long health risks
Suzanne King, Canada
Learning Objectives:
This symposium will
explore how environment, through epigenetic
mechanisms, can contribute to the embed-
ding of early life stress in humans and ani-
mal models.
S-14
SYMPOSIUM
10:00–12:00
Room 11
Track: Translational
Topic: Attention deficit disorders (D)
Prefrontal norepinephrine in arousal and
executive function
Chair:
David Morilak, USA
Co-Chair: Gary Aston-Jones, USA
S-14-001
Functional network effects of selective
LC-NE stimulation
Gary Aston-Jones, USA
S-14-002
Monoaminergic regulation of impulsivity and
gambling-related decision-making
Catharine Winstanley, Canada
S-14-003
The dual role of norepinephrine in modulat-
ing cognitive flexibility in prefrontal cortex:
Acute facilitation and chronic stress-induced
attenuation
David Morilak, USA
J. Jett, M. Girotti, J. Donegan
S-14-004
Noradrenergic modulation of cognitive con-
trol and attention in rodents and humans;
translational implications
Trevor Robbins, United Kingdom
Learning Objectives:
In this symposium del-
egates will learn how norepinephrine, in the
prefrontal cortex, can contribute to arousal
and executive functioning.
S-15
SYMPOSIUM
10:00–12:00
Room 8+15
Track: Translational
Topic: Neurodegenerative disorders, incl.
Parkinson‘s Disease; Alzheimer‘s Disease;
Huntington‘s Disease; Fronto-Temporal De-
mentia; Vascular Dementia (A)
BACE1 in Alzheimer’s disease pathogen-
esis and drug development
Chair:
Weihong Song, Canada
Co-Chair: Debomoy Lahiri, USA
S-15-001
GSK3 signaling regulates BACE1 expression
and APP processing and its pharmaceutical
potential for Alzheimer‘s disease
Weihong Song, Canada
P. Ly, Y. Wu
S-15-002
Alteration of BACE1 processing of APP in
Alzheimer’s disease
Kari Stefansson, Iceland
S-15-003
Inhibition of BACE1 for benefiting AD patients
Riqiang Yan, USA
S-15-004
Dysregulated level of a specific microRNA
in Alzheimer's disease brain and its ability
to regulate BACE1 and amyloid-beta levels
in human brain cultures suggesting a novel
dry target
Debomoy Lahiri, USA
Learning Objectives:
This symposium will focus
on how BACE1 may be involved in both caus-
ing and the treatment of Alzheimer’s disease.
KS-01
SYMPOSIUM
10:00–12:00
Room 10
Korean Session: Neural basis of poor so-
cial functions in schizophrenia
Chair:
Jun Soo Kwon, Republic of Korea
Co-Chair: Sohee Park, USA
KS-01-001
Mismatch negativity, theory of mind, neu-
rocognition, and functional outcomes in pa-
tients with schizophrenia
Seung-Hwan Lee, Republic of Korea
KS-01-002
Neural basis of deficits in emotional experi-
ence and expression in schizophrenia
Jung Suk Lee, Republic of Korea
